Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
Bristol Myers Squibb said the charges primarily reflect its acquisition of Karuna Therapeutics and collaboration agreement with SystImmune.
American Airlines swings to a loss, but tops estimates for Q2 forecast
American Airlines swung to a loss in the first quarter but its forecast for the current period surpassed analysts' estimates.
Red Lobster seeks a buyer as it looks to avoid bankruptcy filing
Beleaguered seafood chain Red Lobster is looking for a buyer to avoid filing for bankruptcy as it contends with slower sales and costly leases.
Southwest cuts growth plans, warning impact of Boeing airplane delays will last into 2025
Southwest Airlines is one of Boeing's biggest customers and flies only 737s.
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
The first-quarter results come as Merck shows substantial progress in preparing for Keytruda's patent expiration in 2028.
Southwest cuts growth plans, warning impact of Boeing airplane delays will last into 2025
Southwest Airlines is one of Boeing's biggest customers and flies only 737s.
American Airlines swings to a loss, but tops estimates for Q2 forecast
American Airlines swung to a loss in the first quarter but its forecast for the current period surpassed analysts' estimates.
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
Bristol Myers Squibb said the charges primarily reflect its acquisition of Karuna Therapeutics and collaboration agreement with SystImmune.